Peer-reviewed publications, announcements from UK Biobank, or significant media reports

UK Biobank's Largest-Ever Study to Analyze 5,400 Proteins in 600,000 Samples

Jan 10, 2025, 01:52 PM

UK Biobank has launched the world's most comprehensive study of proteins circulating in the human body, aimed at transforming research into new medical tests, drugs, and treatments. The study, backed by a consortium of 14 biopharmaceutical companies, will measure up to 5,400 proteins in each of 600,000 samples, including initial and follow-up samples from half a million participants. The research will begin with analyzing 300,000 samples, starting with 250,000 initial samples and 50,000 follow-up samples taken up to 15 years later. The study utilizes the Olink Platform from Thermo Fisher Scientific and the UG 100™ Sequencing Platform from Ultima Genomics. This initiative is expected to lead to significant advancements in understanding disease mechanisms, biomarker discovery, and drug development, potentially revolutionizing healthcare by the end of the decade.